Abstract
The C3H UV—induced skin tumor 1591 is highly immunogenic and is rejected when transplanted into immunocompetent syngeneic C3H mice. We have isolated three MHC class I genes from a genomic tumor library and we show that these genes encode novel class I antigens expressed in 1591 tumor cells but not in normal C3H cells. All three genes account for a restriction fragment length polymorphism in the tumor DNA relative to normal C3H DNA, indicating that the genes were not preexistant in the C3H genome but arose by mutation or recombination. We show that one of the tumor class I genes encodes a highly immunogenic class I antigen which is a target antigen for tumor rejection in immunocompetent hosts.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alter, B. J., Schendel, D. J., Bach, M. L., Bach, F. H., and Stimpfling, J. H., 1973, Cell—mediated lympholysis. Importance of serologically defined H-2 regions., J. Exp. Med., 137: 1303.
Baily, D. W., 1982, How pure are inbred strains of mice., Immunol. Today, 3: 210.
Cepko, C. L., Roberts, B. E., and Mulligan, R. C., 1984, Construction and applications of a highly transmissible retrovirus shuttle vector., Cell, 37: 1053.
Doherty, P. C., and Zinkernagel, R. M., 1975, H-2 compatibility is required for T cell—mediated lysis of target cells infected with lymphocytic choriomeningitis virus., J. Exp. Med., 141: 502.
Doherty, P. C., Knowles, B. B., and Wettstein, P. J., 1984, Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function., Adv. Cancer Res., 42: 1.
Fisher, M. S., and Kripke, M. L., 1978, Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis., Proc. Natl. Acad. Sci. USA, 74: 1688.
Frischauf, A., Lehrach, H., Poustka, A., and Murray, N., 1983, Lambda replacement vectors carrying polylinker sequences., J. Mole. Bio., 170: 827.
Klein, G., Sjogren, H. 0., Klein, E., and Hellstrom, K. E., 1960, Demonstration of resistance against methylcholanthrene—induced sarcomas in the primary autochthonous host., Cancer Res., 20: 1561.
Kripke, M. L., 1981, Immunologic mechanisms in UV radiation carcinogenesis., Adv. Cancer Res., 34: 69.
McMillan, M., Lewis, K. D., and Rovner, D. M., 1985, Molecular characterization of novel H-2 class I molecules expressed by a C3H UV—induced fibrosarcoma., Proc. Natl. Acad. Sci. USA, 82: 5485.
Ozato, K., Hansen, T. H., and Sachs, D., 1980, Monoclonal antibodies to mouse MHC antigens., J. Immunol., 125: 2473.
Parmiani, G., Carbone, G., Invernizzi, G., Pierotti, M. A., Sensi, M. L., Rogers, M. J., and Appela, E., 1979, Alien histocompatibility antigens on tumor cells., Immunogenetics, 9: 1.
Philipps, C., McMillan, M., Flood, P. M., Murphy, D. B., Forman, J., Lancki, D., Womack, J. E., Goodenow, R. S., and Schreiber, H., 1985, Identification of a unique tumor—specific antigen as a novel class I major histocompatibility molecule., Proc. Natl. Acad. Sci. USA, 82: 5140.
Philipps, C., Stauss, H. J., Wortzel, R. D., and Schreiber, H., 1986, A novel MHC class I molecule as tumor—specific antigen: correlation between the antibody—defined and the CTL—defined target structure., J. Immunogenet., (Oxf.), in press.
Prehn, R. T., and Main, J. M., 1957, Immunity to methlcholanthreneinduced sarcomas., J. Natl. Cancer Inst., 18: 769.
Stauss, H. J., Linsk, R., Fischer, A., Watts, S., Banasiak, D., Haberman, A., Clark, I., Forman, J., McMillan, M., Schreiber, H., and Goodenow, R., 1986a, Isolation of the MHC genes encoding the tumor—specific class I antigens expressed on a murine fibrosarcoma., J. Inmunogenet., 13: 101.
Stauss, H. J., Van Waes, C., Fink, M. A., Starr, B., and Schreiber, H., 1986b, Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer., J. Exp. Med., 164: 1516.
Steinmetz, M., Frelinger, J. G., Fisher, D., Hunkapiller, T., Pereira, D., Weissman, S. W., Uehara, H., Nathenson, S. and Hood, L., 1981, Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes., Cell, 24: 125.
Urban, J. L., Burton, R. C., Hôlland, J. M., Kripke, M., and Schreiber, H., 1982, Mechanisms of syngeneic.tumor rejection. Susceptibility of host—selected progressor variants to various immunological effector cells., J. Exp. Med., 155: 557.
Uyttenhove, C., Maryanski, J., and Boon, T., 1983, Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen—loss variants rather than immunosuppression., J. Exp. Med., 157: 1040.
Wortzel, R. D., Philipps, C., and Schreiber, H., 1983, Multiple tumor—specific antigens expressed on a single tumor cell., Nature, 304: 165.
Wortzel, R. D., Urban, J. L., and Schreiber, H., 1984, Ma iT gnant growth in the normal host after variant selection in vitro with cytolytic T cell lines., Proc. Natl. Acad. Sci. USA, 81: 2186.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stauss, H.J., Fink, M.A., Starr, B., Schreiber, H. (1987). Altered MHC Class I Genes Can Encode Immunogenic Antigens that Cause Tumor Rejection. In: David, C.S. (eds) H-2 Antigens. NATO ASI Series, vol 144. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0764-9_61
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0764-9_61
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0766-3
Online ISBN: 978-1-4757-0764-9
eBook Packages: Springer Book Archive